Faeth Therapeutics, Inc.
FTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829802
In the last 90 days, Faeth Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Faeth Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −8 vs. Q2 2022
- Shares held
- 2.88M
- −213.5K (−6.9%) vs. Q2 2022
- Total value
- $4.47M
- −$2.56M (−36.4%) vs. Q2 2022
- New holders
- 4
- 6 more added
- Sold out
- 12
- 13 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $333.8M |
| Q1 2026 | 30 | $72.2M |
| Q4 2025 | 10 | $514.8K |
| Q3 2025 | 9 | $466.5K |
| Q2 2025 | 10 | $600.0K |
| Q1 2025 | 20 | $760.2K |
| Q4 2024 | 24 | $1.16M |
| Q3 2024 | 19 | $1.32M |
| Q2 2024 | 24 | $1.31M |
| Q1 2024 | 25 | $2.45M |
| Q4 2023 | 24 | $2.05M |
| Q3 2023 | 23 | $2.38M |
| Q2 2023 | 26 | $3.58M |
| Q1 2023 | 27 | $4.71M |
| Q4 2022 | 28 | $3.93M |
| Q3 2022 | 31 | $4.47M |
| Q2 2022 | 40 | $7.06M |
| Q1 2022 | 43 | $8.21M |
| Q4 2021 | 38 | $19.7M |
| Q3 2021 | 42 | $37.1M |
| Q2 2021 | 34 | $22.7M |
| Q1 2021 | 40 | $45.8M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Faeth Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 683,529 | $1.06M | 0.02% | −40,020−5.5% | Reduced |
| Vanguard Group Inc | 573,456 | $889.0K | 0.00% | −96,116−14.4% | Reduced |
| Newtyn Management, LLC | 415,000 | $643.0K | 0.14% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 205,800 | $319.0K | 0.00% | −41,200−16.7% | Reduced |
| BlackRock Inc. | 173,950 | $270.0K | 0.00% | −4,944−2.8% | Reduced |
| Bridgeway Capital Management, LLC | 162,900 | $252.0K | 0.01% | +125,000+329.8% | Added |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 100,000 | $155.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 91,895 | $142.0K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 89,967 | $139.0K | 0.00% | −3,631−3.9% | Reduced |
| Millennium Management LLC | 79,081 | $123.0K | 0.00% | −54,624−40.9% | Reduced |
| HighTower Advisors, LLC | 50,229 | $78.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 37,900 | $59.0K | 0.00% | −3,200−7.8% | Reduced |
| Bank of America Corp | 36,906 | $57.0K | 0.00% | +20,035+118.8% | Added |
| Two Sigma Investments, LP | 35,776 | $55.0K | 0.00% | −3,000−7.7% | Reduced |
| State Street Corp | 25,774 | $40.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 26,049 | $40.0K | 0.00% | +10,507+67.6% | Added |
| Raymond James & Associates | 19,000 | $29.0K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 16,711 | $26.0K | 0.00% | −2,042−10.9% | Reduced |
| Morgan Stanley | 13,569 | $21.0K | 0.00% | −12,606−48.2% | Reduced |
| UBS Group AG | 13,114 | $20.0K | 0.00% | −349−2.6% | Reduced |
| Dimensional Fund Advisors LP | 11,570 | $18.0K | 0.00% | +11,570 | New |
| Goldman Sachs Group Inc | 10,446 | $16.0K | 0.00% | −610−5.5% | Reduced |
| Tower Research Capital LLC (TRC) | 4,837 | $7.00K | 0.00% | +455+10.4% | Added |
| Banque Cantonale Vaudoise | 3,900 | $6.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,713 | $3.00K | 0.00% | +412+31.7% | Added |
| Citigroup Inc | 361 | $1.00K | 0.00% | −311−46.3% | Reduced |
| BNP Paribas Arbitrage, SA | 603 | $935 | 0.00% | +603 | New |
| Wells Fargo & Company | 120 | $0 | 0.00% | +59+96.7% | Added |
| Harbour Investments, Inc. | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 77 | $0 | 0.00% | +77 | New |
| China Universal Asset Management Co., Ltd. | 288 | $0 | 0.00% | +288 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −59,380−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −19,934−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −13,917−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −12,901−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −11,223−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,674−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −196−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −199−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −156−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −96−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −162−100.0% | Sold out |
| BFT Financial Group, LLC | – | – | – | – | Not filed |